Patent ID: 7018990

Claim:
A method for treating a thromboembolic disorder, comprising: administering, to a host in need of such treatment, a therapeutically effective amount of: (a) a first therapeutic agent which is 1-(3′-aminobenzisoxazol-5′-yl)-3-trifluoromethyl-5-[[4-[(2′-dimethylaminomethyl)imidazol-1′-yl]-2-fluorophenyl]aminocarbonyl]pyrazole-hydrochloric acid salt (Compound A) or a pharmaceutically acceptable salt form thereof; and, (b) a second therapeutic agent which is Clopidogrel or a pharmaceutically acceptable salt form thereof; wherein said first and second agents are administered in therapeutically effective amounts which provide a synergistic antithrombotic effect.